TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
KZR

Kezar Life Sciences Inc

Healthcare · Biotechnology

0.175$ +6.1% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement KZR
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – -100.0% –
– +13.6% +294.3% +88.6% +18.7% -2.2% -32.3% +4.2% -2.4% -13.7%
– – – – – – – – -114.9% –
– -12.3% +180.4% +50.9% +13.2% +25.7% +31.0% +68.0% -23.3% -48.7%
– +41.0% +189.0% +51.4% +19.9% +31.4% +28.2% +31.7% -11.9% -20.9%
– -2.7% +182.6% +51.0% +15.0% +23.7% +33.9% +66.4% -23.5% -43.3%
– – – – – – – – – –
– – – – – -86.8% +645.3% +30.8% +2.8% -14.0%
– – – – – – – – – –
– – – -328.1% – – – – – –
– – – – – – – – – –
– – – – – – – – – –

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?